Home

CELG

Celgene Corp. (CELG) Contingent Value Rights

By voisin on Sun, 2011-01-02 11:54
(via www.frankvoisin.com)

Lung Cancer is the number one cancer killer globally, claiming approximately 1.2 million lives annually. Non-Small Cell Lung Cancer (NSCLC) is the most common, accounting for 85% of lung cancers. Abraxis Bioscience was a biopharmaceutical company that was recently purchased by Celgene Corp. (CELG).

Pharma, the best of

By moneymaven on Fri, 2010-01-08 12:02
(via www.equithive.com)

the best of pharma - Johnson & Johnson valuation compared against, Celgene, Pfizer, Abbott Laboratories, Merck and Bristol Myers Squibb